A5035681978- Antimicrobial Resistance in Staphylococcus
- Infective Endocarditis Diagnosis and Management
- Bacterial Identification and Susceptibility Testing
- Systemic Lupus Erythematosus Research
- Orthopedic Infections and Treatments
- Atherosclerosis and Cardiovascular Diseases
- Medication Adherence and Compliance
- Bacterial biofilms and quorum sensing
- Cardiovascular Health and Disease Prevention
- Pharmaceutical Practices and Patient Outcomes
- Antibiotic Resistance in Bacteria
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Heart Failure Treatment and Management
- Tuberculosis Research and Epidemiology
- Cardiac electrophysiology and arrhythmias
- Infections and bacterial resistance
Kern Medical Center
2011-2019
University of the Pacific
2016
University of New Mexico
2010
Background In order to reduce Centers for Medicare and Medicaid Services (CMS)‐directed readmission penalties improve patient discharge care, a bedside medication delivery service was developed. Objective To evaluate the impact of pharmacist consultation (Meds‐to‐Beds; MtB) on 30‐day rates at an academic hospital. Methods The pharmacist‐led MtB program established in September 2016. Unplanned data other disease severity indicators were retrospectively collected from 2015 January 2017....
To assess aortic stiffness by transesophageal echocardiography (TEE) and to determine its clinical predictors relation age, blood pressure, renal function, atherosclerosis, 50 patients with systemic lupus erythematosus (SLE), 94% women, a mean age of 38 ± 12 years, 22 gender-matched healthy controls underwent laboratory evaluations multiplane TEE stiffness, intima-media thickness (IMT), plaques the proximal, mid, distal descending thoracic aorta. Stiffness at each level overall...
Stenotrophomonas maltophilia is an inherently multidrug resistant (MDR) opportunistic pathogen with many mechanisms of resistance. SENTRY studies reveal decreasing sensitivities S. to trimethoprim-sulfamethoxazole and fluoroquinolones. Ceftolozane-tazobactam (Zerbaxa, Merck & Co., Inc.) a novel intravenous combination agent third-generation cephalosporin β -lactamase inhibitor was demonstrated have in vitro activity against Gram-positive, Gram-negative, MDR organisms. Data for...
Methicillin-resistant Staphylococcus aureus (MRSA) is a common nosocomial infection that has high burden of morbidity and mortality. Vancomycin the often-used antibiotic choice when MRSA suspected as causative infectious agent. Recent studies have called into question reliability vancomycin empiric therapy, especially in instances bacteremia. The isolate’s minimum inhibitory concentration (MIC), source infection, modality susceptibility testing, resistance are all issues should be taken...